Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SIMSON trial of add-on high-dose simvastatin in multiple sclerosis patients on natalizumab or ocrelizumab
NL-OMON49976Phase 2Not yet recruiting
- Sponsor
- Vrije University Medical Center
- Start
- Jan 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label trial of simvastatin in multiple sclerosis (MS) (2 arms), sponsored by Vrije University Medical Center. Primary endpoint: Change in whole brain atrophy rate. Planned start Jan 2020; status: not yet recruiting.
02
Drugs
simvastatin
03
Conditions
multiple sclerosis (MS)
Beyond the preview
Go deeper on NL-OMON49976.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON49976.